F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
Based on observation, interview, and record review, the facility failed to ensure drugs and biologicals were
stored in accordance with currently accepted professional principles, for 2 of 4 medication carts (3rd floor)
and 2 of 2 medication refrigerators (2nd and 3rd floor) reviewed for medication storage.
1. The facility failed on 06/06/24 to ensure the 2nd floor medication refrigerator was free of discharged
residents' narcotic medications and kept narcotic sheet record.
2. The facility failed on 06/06/24 to ensure the 3rd floor medication cart and medical refrigerator was free of
discharge residents' expired medication and discounted medications (medications that residents were no
longer taking).
These failures could affect all residents by placing them at risk of ingestion/exposure to medications not
intended for them and risk of possible minimized potency from receiving expired medications.
Findings include:
Record review of Resident #1 face sheet revealed she had a planned discharge to home or other
community on 06/03/24.
Record review of Resident#2 face sheet revealed he had a planned discharge to home or other community
on 05/24/24.
Record review of Resident #3 face sheet revealed he had a planned discharge to home or other community
on 09/09/21.
Record review of narcotic book for Resident #2 revealed no narcotic sheet for Resident #2 Lorazepam
2mg/ml 30 ml bottle.
Record review of narcotic book for Resident #3 revealed no narcotic sheet for Resident #3 Lorazepam
2mg/ml 30 ml bottle.
Record review of Resident#5 Prescription orders revealed Novolin 70-30 Flex pen u-100 was started on
05/08/24 and discounted on 06/04/24.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
675757
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675757
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/06/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Signature Pointe
14655 Preston Rd
Dallas, TX 75254
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Observation on 06/06/24 at 10:28 AM of the medication room (2nd floor SNF side) with LVN S revealed (6)
Lantus Solostar insulin pens for Resident #1.
Observation on 06/06/24 at 10:30 AM of the medication room (2nd floor SNF side) with LVN S revealed (1)
30ML bottle of Lorazepam 2mg//ml for Resident #2.
Residents Affected - Some
Observation on 06/06/24 at 10:31 AM of the medication room (2nd floor SNF side) with LVN S revealed (1)
30 ML bottle of Lorazepam 2mg/ml for Resident#3.
Observation on 06/06/24 of the medication cart #1 (3rd floor) revealed Resident#4 had an open expired
Insulin Lisp vial with expiration date of 05/03/24.
Observation on 06/06/24 of the medication cart #2 (3rd floor) revealed Resident#5 had (2)70/30 Novolin
pens on the medication cart that she was no longer taking.
Observation on 06/06/24 of the refrigerator in the medication room revealed (6) 70/30 Novolin pens in a
Ziploc bag and (3) 70/30 Novolin pens in a Ziploc bag that Resident#5 was no longer taking.
Interview on 06/06/24 at 10:35 AM revealed no narcotic sheets for the 2 bottles of 30 ml Lorazepam
2mg/ml. LVN S revealed nursing staff were responsible for giving the medications of discharged residents to
the ADON when the resident was leaving. LVN S revealed the medication would either go with the resident
or be disposed of by the ADON and DON. The LVN S revealed narcotic medication could have been stolen.
Interview on 06/06/24 at 11:30 AM with RN R revealed discharged medication and expired medication was
supposed to be given to the ADON and DON to be disposed of.
Interview on 06/06/24 at 11:45 AM RN E stated according to the manufacturer instructions the medication
was no longer safe for residents to take after insulin pen or vial had been opened for 28 days. RN E stated
the medication effectiveness was no longer useful. RN E stated medication left on the medication cart and
refrigerator that belonged to a resident who no longer took could result in medication error. RN E revealed
resident could get the wrong medication. RN E stated that medication that needed to be dispose of went
into the locked black trash bin in the medication room. RN E stated insulin that needed to be disposed of
goes in a hazard bag and then goes into the locked trashed bin.
Interview on 06/06/24 at 12:00 PM AL Director/ADON (2nd floor SNF side) stated the DON and 2 nurses
must sign off for discharged and expired medication. AL Director/ADON stated when residents are
discharged the medication should have been pulled that same day. AL Director/ADON stated there was not
a narcotic sheet for the 2 bottles of Lorazepam, and they could have stolen.
Interview on 06/06/24 at 12:30PM with Resident#5 revealed she did not know what the name of her insulin.
Interview on 06/06/24 at 12:46 PM DON and ADON stated expired medication should go in the locked trash
bin in the medication room. DON and ADON stated insulin would go in biohazard bags and put in the
locked trash bin. DON and ADON revealed if resident were gone (hospitalized ) for 1 day or more the
medication is supposed to be pulled from the medication cart. DON and ADON stated the wrong dosage of
medication could be given to the resident and cause an adverse reaction and cause a medication error.
DON and ADON stated narcotic medication could disappear if it is not being accounted for.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675757
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675757
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/06/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Signature Pointe
14655 Preston Rd
Dallas, TX 75254
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Record review of the facility policy: Controlled substances revised November 2022, reflected the following:
1. Control substance inventory is monitored and reconciled to identify loss or potential diversion in a
manner that minimizes the time between loss/diversion and detection/follow-up 3. Nursing staff count
controlled medication inventory at the end of each shift, using those records to reconcile the inventory
count.7. Waste and / or disposal of controlled medication are done in the presence of the nurse and a
witness who also signs the disposition sheet .14. Accountability records for discontinued controlled
substances are kept with unused supply until it is destroyed or disposed of as required by applicable law or
regulations.
Review of the facility's policy Administering Medications revised April 2010, reflected the following: 12. The
expiration/beyond date on the medication label is checked .when opening a multi-dose container, the date
opened is recorded on the container.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675757
If continuation sheet
Page 3 of 3